AAPG
Ascentage Pharma Group International
15.90$
-2.5%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.0% | +111.4% | -2.0% | +43.6% | +69.8% | -3.7% | -11.7% | +4.7% | +51.5% | |
| – | -10.6% | +138.8% | -8.2% | +18.7% | +74.7% | -13.2% | -17.9% | +9.7% | +99.8% | |
| – | -95.0% | +6,357.6% | -8.2% | +16.1% | +67.3% | -13.5% | -27.5% | +15.6% | +99.9% | |
| – | -11.7% | +143.5% | -9.6% | +16.1% | +67.3% | -13.5% | -27.5% | +15.6% | +99.9% | |
| – | -5.5% | -33.1% | -51.9% | -81.0% | +11,176.5% | +13.6% | +166.0% | -39.4% | +155.5% | |
| – | – | – | – | – | – | +140.4% | +71.1% | -59.2% | +334.1% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.1% | |
| – | -7.4% | +34.5% | -3.9% | -6.6% | -38.0% | +39.6% | +1.4% | -11.1% | -13.2% | |
| – | +17.4% | +214.1% | -86.0% | +181.1% | +92.8% | +42.0% | +0.3% | -3.5% | +12.3% | |
| – | +2.5% | +32.4% | +91.9% | +36.7% | +30.8% | +144.0% | +6.0% | +24.9% | +41.0% | |
| – | +464.0% | +1,761.7% | +145.3% | -45.2% | -2.2% | +948.3% | +18.9% | +26.4% | +57.0% | |
| – | +2,350.0% | +32.9% | +157.5% | +78.5% | +203.3% | +34.9% | -24.2% | +26.9% | +16.1% | |
| – | – | – | – | – | +117.0% | +23.2% | -7.8% | -25.5% | -14.5% | |
| – | – | – | – | -4.9% | +45.8% | -66.9% | -85.2% | +337.3% | +401.6% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +2.1% | +2.1% | +17.9% | +3.6% | +7.1% | +328.0% | +17.9% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.